[CYCC] QoQ Quarter Result on 31-Mar-2019 [#Q1]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
14-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- 8.72%
YoY- -36.55%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 0 0 0 0 150 0 0 -
PBT -2,752 -2,174 -2,090 -2,110 -2,370 -2,369 -2,354 10.94%
Tax -449 -273 -307 -268 -352 -301 -502 -7.14%
NP -2,303 -1,901 -1,783 -1,842 -2,018 -2,068 -1,852 15.59%
Tax Rate - - - - - - - -
Total Cost 2,303 1,901 1,783 1,842 2,168 2,068 1,852 15.59%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 -1,345.33 0.00 0.00 -
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
EPS -2.68 -2.21 -2.07 -2.70 -2.96 -3.45 -3.09 -9.03%
EPS Diluted -2.68 -2.21 -2.07 -2.70 -2.96 -3.45 -3.09 -9.03%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.